Bicalutamide CAS 90357-06-5 API Fekitari Yepamusoro Yemhando yepamusoro Yepamusoro Prostate Kenza Inoratidzwa Mufananidzo

Bicalutamide CAS 90357-06-5 API Fekitari Yepamusoro Yemhando Yepamusoro Prostate Kenza

Tsanangudzo Pfupi

Zita: Bicalutamide

CAS: 90357-06-5

Chitarisiko: Ichena kusvika Kure-Ichena Crystalline Powder

Chiyero: 98.0% ~ 102.0%

Bicalutamide mukurapa kweAdvanced Prostate Cancer

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Mugadziri Wekutengesa ane Kuchena Kwepamusoro uye Hunhu Hwakagadzikana
Zita: Bicalutamide
CAS: 90357-06-5
Bicalutamide mukurapa kweAdvanced Prostate Cancer
API High Quality, Commercial Production

Chemical Properties:

Zita	Bicalutamide
Mashoko anoreva zvakafanana	N- [4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropionamide
Nhamba yeCAS	90357-06-5
Nhamba yeCAT	RF-API76
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Mazana emaKilogram
Molecular Formula	C18H14F4N2O4S
Molecular Weight	430.37
Storage Temperature	2-8℃
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Ichena kusvika kuOff-White Crystalline Powder
Identification A	IR: Spectrum yemuenzaniso inoenderana neiyo yereferenzi standard
Kuzivikanwa B	HPLC: Nguva yekuchengetedza yepamusoro pepamusoro pemhinduro yemuenzaniso inoenderana neiyo yeyakajairwa mhinduro
Chiziviso C	Organic Fluoride Identification
Solubility	Yakasununguka Soluble muAcetone uye Tetrahydrofuran, Zvishoma Soluble muEthyl Acetate
Melting Point	191.0 ~ 195.0℃
Mvura Yemukati (neKF)	≤0.20%
Fluoride Content	15.9% ~ 18.5%
Kurasika paKuomesa	≤0.50%
Residue paIgnition	≤0.10%
Heavy Metals	≤10ppm
Residual Solvents
Tetrahydrofuran	≤0.072%
Toluene	≤0.089%
N-Hexane	≤0.029%
Acetone	≤0.50%
Ethyl Acetate	≤0.50%
Related Substances
N,N'-Dimethyl Acetamide	≤0.109%
Bicalutamide Aminobenzonitrile	≤0.10%
Bicalutamide Inoenderana Musanganiswa A Isomer A	≤0.10%
Bicalutamide Inoenderana Musanganiswa A Isomer B	≤0.10%
Desfluoro Bicalutamide	≤0.20%
2-Fluoro Bicalutamide	≤0.20%
Deoxy Bicalutamide	≤0.20%
Bicalutamide sulfide	≤0.10%
Chero Kusachena Kusina Kutaurwa	≤0.10%
Zvose Zvisina Kuchena	≤0.50%
Particle Size	90% <10um;50% <5um
Assay	98.0% ~ 102.0% (pane yakaomeswa)
Miedzo yeMicrobiological
Total Viable Aerobic Count	≤500CFU/g
Mbiriso uye Molds	≤50CFU/g
Sherufu Hupenyu	24 Mwedzi
Test Standard	Enterprise Standard;USP Standard
Usage	API, mukurapwa kweAdvanced Prostate Cancer

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

FAQ:

Application:

Bicalutamide (CAS: 90357-06-5) isiri-steroidal androgen antagonist, iyo inokwikwidza androgen receptor ne androgen, inovhara masero ekutorwa kwe androgen, uye inhibits kusungwa kwe androgens kune iyo inotarisirwa nhengo.Inosunga ne androgen receptor iyo inoumba receptor complex, iyo inopinda mukati uye yakabatanidzwa ne nucleoprotein, nokudaro inhibiting tumor cell kukura.Inogona kuve semushonga wekutanga-palliative kurapwa kwepamusoro prostate cancer.Bicalutamide yakavambwa kuUnited Kingdom, musika wayo wekutanga pasi rose, wekurapwa kwegomarara reprostate rakasanganiswa neanalogi yeLHRH kana kuvhiya.A non-steroidal, peripherally selective antiandrogen, bicalutamide inhibisa chiito che dihydrotestosterone uye testosterone panzvimbo dzakanangwa nemakwikwi kusunga kune cytosolic androgen receptor.Yakanzi yakatenderwa zvakanaka pasina yakakosha yemwoyo uye metabolic side effects nekuda kwekubatsirwa kwekushayikwa chero steroid chiitiko.Kushanda kwebicalutamide se monotherapy kwakaratidzwa nekiriniki.Nhamba dzekupindura dzinovimbisa dzakataurwawo mukurapa colorectal, zamu, pancreas uye dzisiri diki cell cancer cancer.